Class Period: August 1, 2022 – August 7, 2024
Lead Plaintiff Deadline: October 28, 2024

For those interested in leading the Outset Medical lawsuit, they can share their contact details via www.glancylaw.com/cases/Outset-Medical-Inc-1/. Alternatively, reach out to Charles H. Linehan at GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com for further clarifications regarding their rights.

Bringing Insights to Light

The allegations state that during the Class Period, the Defendants did not disclose to investors certain crucial information. These include the fact that the Tablo products were promoted for continuous renal replacement therapy, not an indication approved by the FDA. Moreover, it was likely that Outset Medical would need to submit an additional 510(k) application for the Tablo products. There was a significant risk that the Company might halt Tablo sales until FDA approved additional indications. Furthermore, Outset Medical was deemed to lack the necessary sales team and process to drive Tablo sales. Consequently, the Company’s revenue growth would be negatively affected, invalidating Defendants’ optimistic statements about Outset Medical’s business, operations, and prospects as misleading and baseless.

Stay Informed, Stay Ahead

For updates, follow us on LinkedIn, Twitter, or Facebook.

Understanding Your Position

Becoming a part of the class action requires no immediate action. One may choose to retain preferred counsel or remain an uninvolved member of the class action. Should further clarity be sought on this matter or any inquiries arise regarding the impending class action lawsuit, individuals can contact Charles Linehan, Esquire, of GPM, at 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, via email at shareholders@glancylaw.com, or by visiting the website www.glancylaw.com. For email inquiries, please include the mailing address, telephone number, and number of shares purchased.

Defining the Way Forward

Please note that in certain jurisdictions under the applicable law and ethical standards, this press release may be recognized as Attorney Advertising.

Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

Seeking the Full Picture

View original content to download multimedia: https://www.prnewswire.com/news-releases/om-investors-have-opportunity-to-lead-outset-medical-inc-securities-fraud-lawsuit-302248060.html

SOURCE Glancy Prongay & Murray LLP